IN2015DN02929A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN02929A IN2015DN02929A IN2929DEN2015A IN2015DN02929A IN 2015DN02929 A IN2015DN02929 A IN 2015DN02929A IN 2929DEN2015 A IN2929DEN2015 A IN 2929DEN2015A IN 2015DN02929 A IN2015DN02929 A IN 2015DN02929A
- Authority
- IN
- India
- Prior art keywords
- luliconazole
- solubility
- atoms
- improving
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012202514 | 2012-09-14 | ||
| JP2013131504 | 2013-06-24 | ||
| PCT/JP2013/074775 WO2014042231A1 (en) | 2012-09-14 | 2013-09-06 | Crystal and pharmaceutical preparation containing the same crystal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02929A true IN2015DN02929A (es) | 2015-09-18 |
Family
ID=49237577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2929DEN2015 IN2015DN02929A (es) | 2012-09-14 | 2013-09-06 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9012484B2 (es) |
| EP (1) | EP2895165B1 (es) |
| JP (1) | JP5589130B1 (es) |
| CN (1) | CN104284662A (es) |
| IN (1) | IN2015DN02929A (es) |
| RU (1) | RU2622644C2 (es) |
| WO (1) | WO2014042231A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5688406B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| EP2416757A2 (en) | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| KR101754697B1 (ko) | 2009-08-25 | 2017-07-06 | 가부시키가이샤 폴라 파마 | 항진균성 약제학적 조성물 |
| EP2579847A1 (en) | 2010-06-11 | 2013-04-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| RU2603963C2 (ru) | 2012-09-14 | 2016-12-10 | Пола Фарма Инк. | Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5680161B1 (ja) * | 2013-09-06 | 2015-03-04 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| JP5587488B1 (ja) | 2013-12-12 | 2014-09-10 | 株式会社ポーラファルマ | ルリコナゾールを含有する製剤の評価方法及び指標物質 |
| US10703744B2 (en) | 2014-12-12 | 2020-07-07 | Glenmark Life Sciences Limited | Process for preparation of luliconazole |
| JP5951864B1 (ja) * | 2015-06-05 | 2016-07-13 | 株式会社ポーラファルマ | 抗ジアルジア剤 |
| JP2017101009A (ja) | 2015-12-04 | 2017-06-08 | 株式会社ポーラファルマ | 抗アカントアメーバ剤及びその製造法 |
| TR201714882A2 (tr) | 2017-10-03 | 2019-04-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari |
| JP7315055B1 (ja) | 2022-03-16 | 2023-07-26 | カシオ計算機株式会社 | 電子機器 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3081766B2 (ja) | 1994-05-06 | 2000-08-28 | 東興薬品工業株式会社 | 角質貯留型抗真菌外用組成物 |
| JP3278738B2 (ja) | 1995-07-08 | 2002-04-30 | 日本農薬株式会社 | 抗真菌剤 |
| DE19681478B4 (de) * | 1995-07-08 | 2006-09-21 | Nihon Nohyaku Co., Ltd. | R-(-)-(E)-[4-(2,4-Dichlorphenyl)-1,3-dithiolan-2-yliden]-1-imidazolylacetonitril,Verfahren zu seiner Herstellung und seine Verwendung |
| JP2002114680A (ja) | 2000-07-31 | 2002-04-16 | Nippon Nohyaku Co Ltd | 抗真菌剤 |
| CA2645070C (en) | 2006-03-08 | 2014-02-04 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| WO2007102241A1 (ja) | 2006-03-08 | 2007-09-13 | Nihon Nohyaku Co., Ltd. | 外用の医薬組成物 |
| RU2415669C2 (ru) * | 2006-03-08 | 2011-04-10 | Нихон Нохияку Ко., Лтд. | Фармацевтическая композиция для наружного применения |
| WO2009031642A1 (ja) | 2007-09-05 | 2009-03-12 | Pola Pharma Inc. | 医薬組成物 |
| JP5345937B2 (ja) | 2007-09-05 | 2013-11-20 | 株式会社ポーラファルマ | 抗真菌組成物 |
| ES2591030T3 (es) | 2007-09-05 | 2016-11-24 | Pola Pharma Inc. | Composición farmacéutica antifúngica |
| JP5654497B2 (ja) | 2009-02-13 | 2015-01-14 | トピカ ファーマシューティカルズ，インコーポレイテッド | 抗真菌製剤 |
| EP2416757A2 (en) | 2009-04-09 | 2012-02-15 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| JP5688406B2 (ja) | 2009-04-09 | 2015-03-25 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| KR101754697B1 (ko) | 2009-08-25 | 2017-07-06 | 가부시키가이샤 폴라 파마 | 항진균성 약제학적 조성물 |
| EP2579847A1 (en) | 2010-06-11 | 2013-04-17 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| US8728210B2 (en) | 2011-07-07 | 2014-05-20 | Hsueh Yuan Lee | Exhaust gas treatment apparatus and method |
| CN103012385B (zh) * | 2012-02-17 | 2015-07-08 | 山东威智医药工业有限公司 | 卢立康唑的晶型及其制备方法 |
| WO2014041846A1 (en) | 2012-09-14 | 2014-03-20 | Pola Pharma Inc. | Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal |
| US20150238606A1 (en) | 2012-09-14 | 2015-08-27 | Pola Pharma Inc., | Pharmaceutical composition containing luliconazole |
| JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| RU2603963C2 (ru) * | 2012-09-14 | 2016-12-10 | Пола Фарма Инк. | Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
-
2013
- 2013-09-06 IN IN2929DEN2015 patent/IN2015DN02929A/en unknown
- 2013-09-06 WO PCT/JP2013/074775 patent/WO2014042231A1/en active Application Filing
- 2013-09-06 EP EP13766723.4A patent/EP2895165B1/en active Active
- 2013-09-06 RU RU2015113638A patent/RU2622644C2/ru active
- 2013-09-06 JP JP2013185320A patent/JP5589130B1/ja active Active
- 2013-09-06 CN CN201380018386.2A patent/CN104284662A/zh active Pending
- 2013-09-06 US US14/019,997 patent/US9012484B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9012484B2 (en) | 2015-04-21 |
| WO2014042231A1 (en) | 2014-03-20 |
| EP2895165B1 (en) | 2016-12-14 |
| RU2622644C2 (ru) | 2017-06-19 |
| EP2895165A1 (en) | 2015-07-22 |
| RU2015113638A (ru) | 2016-11-10 |
| US20140080882A1 (en) | 2014-03-20 |
| JP2015027972A (ja) | 2015-02-12 |
| JP5589130B1 (ja) | 2014-09-10 |
| CN104284662A (zh) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN02929A (es) | ||
| PH12016500611A1 (en) | Compositions useful for treating disorders related to kit | |
| IN2015DN02376A (es) | ||
| CO7111289A2 (es) | Compuestos inhibidores de metaloenzimas | |
| PH12015501083A1 (en) | Novel pyridine derivatives | |
| PH12015501843A1 (en) | Novel pyrazol derivatives | |
| MX339992B (es) | Piridin-2-amidas utiles como agonistas canabinoides 2 (cb2). | |
| SG10201805410XA (en) | Therapeutic agent or prophylactic agent for dementia | |
| UA114655C2 (uk) | Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2 | |
| IN2014DN09085A (es) | ||
| MX2013015308A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
| UA116239C2 (uk) | Нові похідні піридину | |
| IN2015DN03928A (es) | ||
| UA116654C2 (uk) | Похідні пурину як агоністи канабіноїдного рецептора св2 | |
| IN2013DE00266A (es) | ||
| UA111333C2 (uk) | Спосіб одержання l-аргінінової солі периндроприлу | |
| GEP201706626B (en) | Synthesis of (s)-nifuratel | |
| AU2014371081A1 (en) | Polyoxalates and a Process for the Production Thereof | |
| AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
| MX2014008918A (es) | Nuevos derivados de pirrolidina. | |
| IN2014DN10658A (es) | ||
| IN2014DN08443A (es) | ||
| IN2014KN01772A (es) | ||
| AU341949S (en) | Cleaning tray | |
| MX2016007130A (es) | Nuevo procedimiento de sintesis del 7-metoxi-naftaleno-1-carbaldeh ido y aplicacion en la sintesis de la agomelatina. |